Humacyte Company
Humacyte is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at a commercial scale to improve the lives of patients and transform the practice of medicine.
Investors
Connections from
Total Funding:
$400 000 000
Headquarters:
United States
Funding Status:
Private investment in public equity(PIPE)
Employee Number:
101-250
Estimated Revenue:
$10-50 Mn
Last Funding Type:
Reverse Merger
Technology:
Specific disorder-related
Last Funding Date:
17.02.2021
Investors Number:
9
Founded Date:
01.01.2004
Industry:
Longevity